Literature DB >> 25442460

Common carotid intima-media thickness as a risk factor for outcomes in Asian patients with acute ST-elevation myocardial infarction.

Sahmin Lee1, Goo-Yeong Cho2, Hyun-Sook Kim3, Yeonyee E Yoon4, Seung-Pyo Lee1, Hyung-Kwan Kim1, Yong-Jin Kim1, Dae-Won Sohn1.   

Abstract

BACKGROUND: Carotid intima-media thickness (CIMT) is associated with an increased risk of cardiovascular disease. We studied whether CIMT predicts the prognosis of Asian patients with acute ST-elevation myocardial infarction (STEMI).
METHODS: A total of 345 patients with STEMI (men, 82.9%; age, 59 ± 13 years) treated with emergent revascularization were prospectively investigated. In all patients, common CIMT was measured with high-resolution ultrasonography. The patients were followed for a median period of 583 days, and the primary end point was major adverse cardiovascular events (MACE) defined as a composite of cardiovascular death, heart failure, nonfatal recurrent MI, revascularization, and stroke.
RESULTS: Mean CIMT of the patients with STEMI was 0.77 ± 0.14 mm. Of the total patients, 20.6% had carotid plaque and 11.0% experienced MACE. Killip class, left ventricular (LV) function, and carotid plaque were associated with 30-day MACE, whereas CIMT and carotid plaque were related to overall MACE. After adjusting for age, the event rate was 19.0% in the third-tertile CIMT (≥ 0.83 mm) group, 12.1% in the second-tertile (0.70-0.82 mm) group, and 4.3% in the first-tertile (≤ 0.69 mm) group (P = 0.01). Carotid plaque was independently associated with a higher incidence of MACE (adjusted odds ratio [OR], 3.7; 95% confidence interval [CI], 1.327-10.234; P = 0.012). Area under the receiver operating characteristic (ROC) curve for CIMT tertile (0.69 ± 0.05) was significantly larger compared with those for door-to-balloon time (0.55 ± 0.05), LV ejection fraction (LVEF) (0.49 ± 0.05), and Killip class (0.48 ± 0.05) (P < 0.001).
CONCLUSIONS: CIMT was a useful prognosticator to predict future cardiovascular events (CVEs) in Asian patients with STEMI.
Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25442460     DOI: 10.1016/j.cjca.2014.06.026

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  Relationship between carotid atherosclerosis and coronary artery calcification in asymptomatic diabetic patients: A prospective multicenter study.

Authors:  Anand Jeevarethinam; Shreenidhi Venuraju; Alain Dumo; Sherezade Ruano; Vishal S Mehta; Miranda Rosenthal; Devaki Nair; Mark Cohen; Daniel Darko; Avijit Lahiri; Roby Rakhit
Journal:  Clin Cardiol       Date:  2017-05-25       Impact factor: 2.882

Review 2.  Early Detection System of Vascular Disease and Its Application Prospect.

Authors:  Huan Liu; Hongyu Wang
Journal:  Biomed Res Int       Date:  2016-11-30       Impact factor: 3.411

Review 3.  Is Carotid Artery Ultrasound Still Useful Method for Evaluation of Atherosclerosis?

Authors:  Gee-Hee Kim; Ho-Joong Youn
Journal:  Korean Circ J       Date:  2016-11-24       Impact factor: 3.243

4.  Risk Factors of Subclinical Atherosclerosis and Plaque Burden in High Risk Individuals: Results From a Community-Based Study.

Authors:  Lianduo Bian; Lili Xia; Yixin Wang; Jiajia Jiang; Yonghui Zhang; Dongxue Li; Wei Li; Yan He
Journal:  Front Physiol       Date:  2018-06-22       Impact factor: 4.566

Review 5.  Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials.

Authors:  Michiel L Bots; Gregory W Evans; Charles H Tegeler; Rudy Meijer
Journal:  Chin Med J (Engl)       Date:  2016-01-20       Impact factor: 2.628

6.  LDL-C:HDL-C ratio and common carotid plaque in Xinjiang Uygur obese adults: a cross-sectional study.

Authors:  Qiang Zhao; Fen Liu; Ying-Hong Wang; Hong-Mei Lai; Qian Zhao; Jun-Yi Luo; Yi-Tong Ma; Xiao-Mei Li; Yi-Ning Yang
Journal:  BMJ Open       Date:  2018-10-08       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.